Pathophysiology of hypertension in response to placental ischemia during pregnancy: A central role for endothelin?

Gender Medicine

Volumn 5, Issue SUPPL. 1, 2008, Pages

  LaMarca, Babbette D ^a   Alexander, Barbara T ^a   Gilbert, Jeffery S ^a   Ryan, Michael J ^a   Sedeek, Mona ^a   Murphy, Sydney R ^a   Granger, Joey P ^a  

^a UNIVERSITY OF MISSISSIPPI MEDICAL CENTER   (United States)

Author keywords

cytokines; endothelin; hypertension; preeclampsia; pregnancy

Indexed keywords

ATRASENTAN; ENDOTHELIN; ENDOTHELIN A RECEPTOR; ENDOTHELIN A RECEPTOR ANTAGONIST; TUMOR NECROSIS FACTOR ALPHA;

ARTERIAL PRESSURE; ARTICLE; BLOOD PRESSURE; DISEASE MODEL; FEMALE; HUMAN; ISCHEMIA; MATERNAL HYPERTENSION; MEDLINE; NONHUMAN; PATHOPHYSIOLOGY; PERFUSION PRESSURE; PHARMACOLOGICAL BLOCKING; PLACENTA DISORDER; PREECLAMPSIA; PREGNANCY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN FUNCTION; PROTEIN SYNTHESIS; UTERUS;

ANIMALS; DISEASE MODELS, ANIMAL; ENDOTHELINS; FEMALE; HUMANS; PLACENTA; PLACENTAL INSUFFICIENCY; PRE-ECLAMPSIA; PREGNANCY; RECEPTOR, ENDOTHELIN A; TUMOR NECROSIS FACTOR-ALPHA;

EID: 41449111267     PISSN: 15508579     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.genm.2008.03.013     Document Type: Article

References (41)

1. Sibai B., Dekker G., and Kupferminc M. Preeclampsia. Lancet. 365 (2005) 785-799
2. Roberts J., Pearson G., Cutler J., Lindheimer M., and for the NHLBI Working Group on Research on Hypertension During Pregnancy. Summary of the NHLBI Working Group on Research on Hypertension During Pregnancy. Hypertension. 41 (2003) 437-445
3. Sibai B., Caritis S., Hauth J., and for the National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network. What we have learned about preeclampsia. Semin Perinatol. 27 (2003) 239-246
4. Roberts J., Taylor R., Musci T., et al. Preeclampsia: An endothelial cell disorder. Am J Obstet Gynecol. 161 (1989) 1200-1204
5. Redman C. Current topic: Pre-eclampsia and the placenta. Placenta. 12 (1991) 301-308
6. Khalil R., and Granger J. Vascular mechanisms of increased arterial pressure in preeclampsia: Lessons from animal models. Am J Physiol Regul Integr Comp Physiol. 283 (2002) R29-R45
7. Yanagisawa M., Kurihara H., Kimura S., et al. A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature. 332 (1988) 411-415
8. Kohan D. Endothelins in the normal and diseased kidney. Am J Kidney Dis. 29 (1997) 22-26
9. Schiffrin E. Endothelin: Potential role in hypertension and vascular hypertrophy. Hypertension. 25 (1995) 1135-1143
10. Simonson M., and Dunn M. Endothelin peptides and the kidney. Annu Rev Physiol. 55 (1993) 249-265
11. Schiffrin E. Vascular endothelin in hypertension. Vascul Pharmacol. 43 (2005) 19-29
12. Taylor R., Varma M., Teng N., and Roberts J. Women with preeclampsia have higher plasma endothelin levels than women with normal pregnancies. J Clin Endocrinol Metab. 71 (1990) 1675-1677
13. Mastrogiannis D., O'Brien W., Krammer J., and Benoit R. Potential role of endothelin-11 in normal and hypertensive pregnancies. Am J Obstet Gynecol. 165 (1991) 1711-1716
14. McMahon L., Redman C., and Firth J. Expression of the three endothelin genes and plasma levels of endothelin in pre-eclamptic and normal gestations. Clin Sci (Lond). 85 (1993) 417-424
15. Benigni A., Orisio S., Gaspari F., et al. Evidence against a pathogenetic role for endothelin in preeclampsia. Br Obstet Gynecol. 99 (1992) 798-802
16. Wilkins Jr. F., Alberola A., Mizelle H., et al. Systemic hemodynamics and renal function during longterm pathophysiological increases in circulating endothelin. Am J Physiol. 268 (1995) R375-R381
17. Napolitano M., Miceli F., Calce A., et al. Expression and relationship between endothelin-11 messenger ribonucleic acid (mRNA)and inducible/endothelial nitric oxide synthase mRNA isoforms from normal and preeclamptic placentas. J Clin Endocrinol Metab . 85 (2000) 2318-2323
18. Rogers R., and Thorpe Jr. J. Pregnancy-induced hypertension: Genesis of and response to endothelial injury and the role of endothelin 1. Obstet Gynecol Surv. 52 (1997) 723-727
19. Faxen M., Nasiell J., Lunell N., and Blanck A. Differences in mRNA expression of endothelin-11, c-fos and c-jun in placentas from normal pregnancies and pregnancies complicated with preeclampsia and/or intrauterine growth retardation. Gynecol Obstet Invest. 44 (1997) 93-96
20. Granger J., Alexander B., Llinas M., et al. Pathophysiology of hypertension during preeclampsia linking placental ischemia with endothelial dysfunction. Hypertension. 38 (2001) 718-722
21. Granger J., LaMarca B., Cockrell K., et al. Reduced uterin ne perfu usio on pressu ure (RR model for studying cardiovascular-renal dysfunction in response to placental ischemia. Methods Mol Med. 122 (2006) 383-392
22. Conrad K. Animal models of preeclampsia: Do they exist?. Fetal Med Rev 2 (1990) 67-88
23. Crews J., Herrington J., Granger J., and Khalil R. Decreased endothelium-dependent vascular relaxation during reduction of uterine perfusion pressure in pregnant rats. Hypertension. 35 (2000) 367-372
24. Alexander B., Kassab S., Miller M., et al. Reduced uterine perfusion pressure during pregnancy in the rat is associated with increases in arterial pressure and changes in renal nitric oxide. Hypertension. 37 (2001) 1191-1195
25. Llinas M., Alexander B., Seedek M., et al. Enhanced production of thromboxane A2 in response to chronic reductions in uterine perfusion pressure in pregnant rats. Am J Hypertens. 15 (2002) 793-797
26. Llinas M., Alexander B., Capparelli M., et al. Cytochrome P-4450 inhibition attenuates hypertension induced by reductions in uterine perfusion pressure in pregnant rats. Hypertension. 43 (2004) 623-628
27. Alexander B., Llinas M., Kruckeberg W., and Granger J. L-aarginine attenuates hypertension in pregnant rats with reduced uterine perfusion pressure. Hypertension. 43 (2004) 832-836
28. LaMarca B., Bennett W., Alexander B., et al. Hypertension produced by reductions in uterine perfusion in the pregnant rat: Role of tumor necrosis factor-alpha. Hypertension. 46 (2005) 1022-1025
29. Gadonski G., LaMarca B., Sullivan E., et al. Hypertension produced by reductions in uterine perfusion in the pregnant rat: Role of interleukin 6. Hypertension. 48 (2006) 711-716
30. Alexander B., Rinewalt A., Cockrell K., et al. Endothelin type A receptor blockade attenuates the hypertension in response to chronic reductions in uterine perfusion pressure. Hypertension. 37 (2001) 485-489
31. Lefer A., and Ma X. Cytokines and growth factors in endothelial dysfunction. Crit Care Med. 21 Suppl 2 (1993) S9-S14
32. Meekins J., McLaughlin P., West D., et al. En ndothelial cell activation by tumour necrosis factor-alpha (TNF-α)and the development of pre-eclampsia. Clin Exp Immunol. 98 (1994) 110-114
33. Benyo D., Smarason A., Redman C., et al. Expression of inflammatory cytokines in placentas from women with preeclampsia. J Clin Endocrinol Metab. 86 (2001) 2505-2512
34. Kupferminc M., Peaceman A., Wigton T., et al. Tumor necrosis factor-alpha is elevated in plasma and amniotic fluid of patients with severe preeclampsia. Am J Obstet Gynecol. 170 (1994) 1752-1757
35. Visser W., Beckmann I., Bremer H., et al. Bioactive tumour necrosis factor alpha in preeclamptic patients with and without the HELLP syndrome. Br J Obstet Gynaecol. 101 (1994) 1081-1082
36. Vince G., Starkey P., Austgulen R., et al. Interleukin-6, tumour necrosis factor and soluble tumour necrosis factor receptors in women with preeclampsia. Br J Obstet Gynaecol. 102 (1995) 20-25
37. Gilbert J., Babcock S., and Granger J. Hypertension produced by reduced uterine perfusion in pregnant rats is associated with increased soluble fms-like tyrosine kinase-11 expression. Hypertension. 50 (2007) 1142-1147
38. Karumanchi S., and Bdolah Y. Hypoxia and sFlt-11 in preeclampsia:The 'chicken-and-egg' question. Endocrinology. 145 (2004) 4835-4837
39. Roberts L., LaMarca B., Fournier L., et al. Enhanced endothelin synthesis by endothelial cells exposed to sera from pregnant rats with decreased uterine perfusion. Hypertension. 47 (2006) 615-618
40. Marsden P., and Brenner B. Transcriptional regulation of the endothelin-11 gene by TNF-α. Am J Physiol. 262 (1992) C854-C861
41. LaMarca B., Cockrell K., Sullivan E., et al. Role of endothelin in mediating tumor necrosis factor-induced hypertension in pregnant rats. Hypertension. 46 (2005) 82-86